Delivery Order SPE2DB20D1109-SPE2DB23FP11X
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The $7,777.43 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a...
- This federal contract award, valued at $4,501.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,062.10 firm fixed price delivery order is for the supply of VASCEPA 1 GM capsules. The contract has a period of performance through March 30, 2023. This award is not designated as a set-aside contract. The contract is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $1,286.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of the cardiovascular medication VASCEPA 1 GM CAPSULE 120S. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award has a ceiling value of $1,201.32 and an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
- This federal contract award is for the delivery of VASCEPA 1 GM CAPSULE 120S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $7,525.73, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 15, 2023, with a completion date of February 16, 2023. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. The award is not designated as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vascepa 1 GM capsules. The contract is a Firm Fixed Price Delivery Order valued at $1,269.75 with an ultimate completion date of August 18, 2021. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VASCEPA 1 GM CAPSULE 120S. The contract has a ceiling value of $4,359.73 and a period of performance through June 1, 2023. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, involves the delivery of VASCEPA 1 GM CAPSULE 120S to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 through December 31, 2025, and serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Department of...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product. The contract has a potential value of $2,360.97 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP11XDelivery Order
This federal contract award, valued at $1,431.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product. This appears to be a firm-fixed-price delivery order contract with a completion date of May 12, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/11/23 |